
Photo: STAT
Health
STAT+: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issues
TL;DR
- Versant Ventures, Eli Lilly, and a handful of other investors will pour $100 million into a new startup devoted to solving a thorny gene therapy challenge.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 16, 2026 · Updated 11/16/2026, 10:05:01 AM · Reported with: STAT
Sources (1)
NRI Bytes writes its own articles from the reporting below.
STAT — STAT+: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issuesUp next · Health
Hospital in Chennai performs complex aortic surgery on 10-year-old boy with rare vascular disease
Read next →
More stories

Health
STAT+: ‘Medicare for More’ gains traction
1h ago
Health
Chinese scientist fired after child death in gene-editing trial: state media
1h ago
Health
Olivia Munn and Alison Hall discuss fighting for breast cancer awareness on Capitol Hill
1h ago
Health
Microplastics, 'cocktail' of hazardous chemicals in Delhi's Yamuna, flags study
2h ago

